BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Trends Analyst Outlook Journalist POV

61 hedge funds and large institutions have $2.7B invested in BridgeBio Pharma in 2019 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$995M
2
+$718M
3
+$182M
4
PA
Perceptive Advisors
New York
+$181M
5
ACM
Aisling Capital Management
New York
+$103M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$135K
52
$76K
53
$20K
54
$17K
55
$16K
56
$13K
57
$13K
58
$10K
59
$8K
60
$6K
61
$2K
1 2
3